Hongye Wang

Hongye Wang

Auto-generated profile, based on publicly available information

Hongye Wang

Shanghai Jiao Tong University School of Medicine

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in International Journal of Hyperthermia
Verified
Journal Article
Open access
KSKangjie Shen
Kangjie Shen
SXShengbai Xue
Shengbai Xue
YXYi Xie
Yi Xie
HWHongye Wang
Hongye Wang
JLJing Li
Jing Li
ARAnjing Ren
Anjing Ren
Thermal ablation (TA), as an alternative to surgery, has shown some benefits in the treatment of papillary thyroid microcarcinoma (PTMC) patients, especially for those who are at high risk for surg...

22 January 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
HWHongye Wang
Hongye Wang
ZWZhaorong Wu
Zhaorong Wu
DCDan Cui
Dan Cui
LBLinke Bian
Linke Bian
ZZZhigang Zheng
Zhigang Zheng
BZBo Zhai
Bo Zhai
Chimeric antigen receptor (CAR)–T cell therapies have revolutionized the landscape of cancer treatment, in particular in the context of hematologic malignancies. However, for solid tumors that lack tumor-specific antigens, CAR-T cells can infiltrate and attack nonmalignant tissues expressing the CAR target antigen, leading to on-target, off-tumor toxicity. Severe on-target, off-tumor toxicities have been observed in clinical trials of CAR-T therapy for solid tumors, highlighting the need to address this issue. Here, we demonstrated that targeting the cell adhesion and migration molecules lymphocyte function–associated antigen 1 (LFA-1; CD11a/CD18) and very late activation antigen 4 (VLA-4; CD49d/CD29) with blocking antibodies reduced the on-target, off-tumor toxicity of CAR-T cells in mice. To translate this observation into improved CAR-T cell therapy, we either knocked out both CD11a and CD49d or knocked down CD11a and CD49d along with PSGL1 , another cell adhesion molecule, in CAR-T cells. We found that these modified CAR-T cells exhibited reduced on-target, off-tumor toxicity in vivo without affecting CAR-T cell efficacy. Furthermore, we showed that this approach promoted T cell memory formation and decreased tonic signaling. On the basis of these data, we engineered a human version of these low-toxicity CAR-T cells and further validated the feasibility of this approach in vitro and in vivo. Together, these results provide a potential solution to address the clinical challenge of on-target, off-tumor toxicity in CAR-T therapy.

12 March 2020 in BMC Pharmacology and Toxicology
Verified
Journal Article
Open access
PDF file
JNJie Ni
Jie Ni
HWHongye Wang
Hongye Wang
XWXiyi Wei
Xiyi Wei
KSKangjie Shen
Kangjie Shen
YSYeqin Sha
Yeqin Sha
YLYihai Liu
Yihai Liu
Background: The cardiotoxicity of isoniazid on zebrafish embryos and its underlying mechanism is unclear.Methods: Here, we exposed zebrafish embryos at 4 h post-fertilization to different levels of isoniazid and recorded the morphology and number of malformed and dead embryos under the microscope.Results: The high concentration of isoniazid group showed more malformed and dead embryos than the low concentration of isoniazid group and control group. The morphology of the heart and its alteration were visualized using transgenic zebrafish (cmlc2: GFP) and confirmed by in situ hybridization. The negative effects of isoniazid on the developing heart were characterized by lower heart rate and more heart looping disorders. Mechanistically, PCR showed decreased expression of heart-specific transcription factors when exposed to isoniazid. Oxidative stress was induced by isoniazid in cardiomyocytes, mediated by decreased activities of catalase and superoxide dismutase, which were rescued by scavengers of reactive oxygen species.Conclusion: In conclusion, this study demonstrated that isoniazid led to heart looping disturbance by the downregulation of cardiac-specific transcription factors and induction of cardiomyocyte apoptosis.

21 April 2024 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
YPYixiao Pan
Yixiao Pan
ZZZhigang Zheng
Zhigang Zheng
XZXueliang Zhang
Xueliang Zhang
SLShupeng Liu
Shupeng Liu
SZShiya Zhuansun
Shiya Zhuansun
KHKang He
Kang He

1 December 2019 in Translational Andrology and Urology
Verified
Journal Article
Open access
PDF file
XWXiyi Wei
Xiyi Wei
XRXiaohan Ren
Xiaohan Ren
YDYichao Ding
Yichao Ding
HWHongye Wang
Hongye Wang
YLYunxin Li
Yunxin Li
YGYang Gao
Yang Gao
Background: The role of radio frequency ablation (RFA) in small renal tumors remains controversial. This systematic review was performed to compare clinical outcomes of RFA versus partial nephrectomy (PN) for the treatment of T1 renal tumors. Methods: A total of 11 studies including 2,397 patients were analyzed in this systematic review after searching the databases of PubMed, EMBASE and Web of Science. P value and odds ratio (OR)/hazard ratio (HR) with 95% confidence interval (CI) were used to evaluate the strength of the association. Results: A total of six studies (2,056 patients) provided either survival curves or HR and its 95% CI, demonstrating that the majority of the patients with RFA treatment tended to exhibit a similar long-term survival rate to those with PN treatment. In addition, according to four studies, no differences were found in the overall rate of complications between the two groups. Furthermore, there were significant differences in glomerular filtration rate (GFR) change between the two methods in four studies but no differences were observed in other two. Conclusions: Our systematic review indicated that RFA is an effective treatment option which could provide comparable oncologic outcomes to PN. Moreover, it may present obvious advantages in renal function preservation.

1 October 2020 in Translational Andrology and Urology
Verified
Journal Article
Open access
PDF file
XWXiyi Wei
Xiyi Wei
WWWei Wang
Wei Wang
HWHongye Wang
Hongye Wang
YWYamin Wang
Yamin Wang
YWYichun Wang
Yichun Wang
CQChao Qin
Chao Qin
Background: Autophagy was a significant catabolic process which played a critical role in the maintenance of cellular homeostasis and viability in a stressed state. The dysregulation of autophagy was correlated with various diseases. The aim of our study was to develop a prognostic signature for papillary renal cell carcinoma (RCC). Methods: First, 40 differently expressed genes related with autophagy (ARGs) were examined via high-throughput sequencing and large-scale databases. Then, functional enrichment analysis was performed to explore the biological attributes of these ARGs. The Cox proportional hazard regression hinted that four ARGs (P4HB, BIRC5, NGR1 and PRKN) were significantly correlated with overall survival (OS). Thus, we got genes with prognostic value. Finally, a prognostic index (PI) was constructed. Results: After identifying the 4 ARGs, we profiled our risk signature. Based on the PI we developed, papillary RCC patients were stratified into high-risk and low-risk groups. High-risk patients had significant shorter OS than low-risk patients (P<0.001) and the mortality of high scoring patients was higher than low scoring patients. Additionally, we explored the relationship between the 4 ARGs and clinical parameters and found that the expression of P4HB, BIRC5 and NGR1 was correlated with clinicopathological features. Conclusions: Our study suggested that the four-gene signature was an independent prognostic factor which could act as a novel indicator for the prognosis of papillary RCC.